Compare Abbott Laboratories (ABT) vs Shopify Inc. (SHOP) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Shopify Inc. — how do they compare? Abbott Laboratories trades at $95.37 (market cap $166.94B), while Shopify Inc. trades at $117.71 (market cap $158.16B). The key difference: Abbott Laboratories and Shopify Inc. are close in size by market cap, and Abbott Laboratories pays a 2.63% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals.
| ABT | SHOP | |
|---|---|---|
Market Cap | $166.94B | $158.16B |
Sector | Health | Technology |
52-Week High | $136.62 | $179.01 |
52-Week Low | $82.57 | $95.40 |
Enterprise Value | $193.69B | $152.59B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Shopify (SHOP) trades at $121.88, up 2.03% on the day, with a bullish technical setup showing strong moving average signals and support near $117. Revenue grew to $11.56B in 2025 with a 10.77% net margin, though valuation multiples remain elevated. Recent news highlights Bank of America reinstating a Buy rating with a $150 target, citing AI commerce tools and partnership developments.
Outlook is positive with analyst consensus at $149.10 and 63% Buy ratings, but high P/E of 117.78 poses valuation risk. Key opportunities include AI-driven growth and expanding merchant services, while risks involve competitive pressures and reliance on e-commerce trends. Cash flow trends show improving operations, supporting continued investment in innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
